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Abstract
Background
Enterotoxigenic Escherichia coli (ETEC) encoding heat-stable enterotoxin (ST) alone or
with heat-labile enterotoxin (LT) cause moderate-to-severe diarrhea (MSD) in developing
country children. The Global Enteric Multicenter Study (GEMS) identified ETEC encoding
ST among the top four enteropathogens. Since the GEMS objective was to provide evi-
dence to guide development and implementation of enteric vaccines and other interventions
to diminish diarrheal disease morbidity and mortality, we examined colonization factor (CF)
prevalence among ETEC isolates from children age <5 years with MSD and from matched
controls in four African and three Asian sites. We also assessed strength of association of
specific CFs with MSD.
Methodology/Principal findings
MSD cases enrolled at healthcare facilities over three years and matched controls were
tested in a standardized manner for many enteropathogens. To identify ETEC, three E. coli
colonies per child were tested by polymerase chain reaction (PCR) to detect genes encod-
ing LT, ST; confirmed ETEC were examined by PCR for major CFs (Colonization Factor
Antigen I [CFA/I] or Coli Surface [CS] antigens CS1-CS6) and minor CFs (CS7, CS12,
CS13, CS14, CS17, CS18, CS19, CS20, CS21, CS30). ETEC from 806 cases had a single
toxin/CF profile in three tested strains per child. Major CFs, components of multiple ETEC
vaccine candidates, were detected in 66.0% of LT/ST and ST-only cases and were associ-
ated with MSD versus matched controls by conditional logistic regression (p�0.006); major
CFs detected in only 25.0% of LT-only cases weren’t associated with MSD. ETEC encoding
exclusively CS14, identified among 19.9% of 291 ST-only and 1.5% of 259 LT/ST strains,
were associated with MSD (p = 0.0011). No other minor CF exhibited prevalence�5% and
significant association with MSD.
Conclusions/Significance
Major CF-based efficacious ETEC vaccines could potentially prevent up to 66% of pediatric
MSD cases due to ST-encoding ETEC in developing countries; adding CS14 extends cover-
age to ~77%.
Author summary
Enterotoxigenic Escherichia coli (“ETEC”) were found to be one of the four most consis-
tently important agents that cause moderate-to-severe diarrhea among children <5 years
of age in a large case-control study, the Global Enteric Multicenter Study, performed in
four countries in sub-Saharan Africa and three in South Asia. ETEC attach to the lining of
the human small intestine by means of protein colonization factors (CFs), after which bac-
terial toxins stimulate intestinal secretion resulting in diarrhea. Moderate-to-severe diar-
rhea in young children in developing countries can lead to malnutrition and death.
Vaccines are being developed to prevent ETEC diarrhea and its consequences. Several
ETEC colonization factors from a global diarrhea study
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ETEC vaccines aim to stimulate antibodies (protective proteins) that will bind CFs and
prevent the bacteria from attaching to intestinal cells, which should, in turn, prevent
ETEC diarrhea. Different types of CFs exist. To guide the development of vaccines intend-
ing to provide broad protection against ETEC, one must know the frequency with which
the different major CFs are produced by ETEC. This paper reports an extensive systematic
survey of ETEC CFs and provides helpful information to guide the development of ETEC
vaccines.
Introduction
Enterotoxigenic Escherichia coli (ETEC) cause diarrheal disease in children <5 years of age in
developing countries and travelers’ diarrhea among persons from industrialized countries who
visit developing countries [1,2]. Human ETEC strains can produce a heat-labile enterotoxin
(LT) that resembles cholera toxin and one or more heat-stable enterotoxins (ST) including
human ST (STh) or porcine ST (STp). Strains can produce both LT and ST (LT/ST) or be ST-
only or LT-only. Most ETEC encode colonization factors (CFs) that allow the pathogen to
attach to proximal small intestine enterocytes, the critical site of host-parasite interaction,
before expressing enterotoxins that decrease villus tip cell absorption and evoke secretion of
electrolytes and water by crypt cells [3].
Three main families of Colonization Factor Antigens (CFAs) are encoded by ETEC that
cause diarrhea in humans including CFA/I, CFA/II and CFA/IV [3]. CFA/I is the sole member
of the first family. CFA/II strains encode coli surface (CS) antigen 3 (CS3) alone or in combi-
nation with CS1 or CS2 [3], while CFA/IV strains encode CS6 alone or in conjunction with
CS4 or CS5 [3]. CFA/I, CS1, CS2, CS4 and CS5 are rigid fimbriae ~6–7 nm in diameter, CS3
are thin flexible fibrillae 2–3 nm in diameter [4], and CS6 morphology is nondescript.
ETEC vaccines intending to stimulate anti-CF immunity, with or without accompanying
antitoxin immunity, are in clinical development. These include purified fimbriae or tip adhe-
sins [5], inactivated fimbriated ETEC [6], attenuated ETEC expressing CFs [7], bacterial live
vectors such as Shigella encoding ETEC CFs [8], multiple epitope fusion antigens [9], and ST
toxoids [10]. Stimulating intestinal secretory IgA antibodies that bind CFs and prevent ETEC
from attaching to human small intestine mucosa is generally considered to be fundamental to
a successful ETEC vaccine, although some contend that parenteral vaccine-induced serum IgG
antibodies that transude onto intestinal mucosa may also prevent diarrhea in humans caused
by bacterial enteropathogens [11]. Most current ETEC vaccines contain a mix of antigens
directed against CFA/I, CFA/II and CFA/IV antigens.
Minor putative CFs also exist for which data supporting their role in pathogenesis in
humans is less compelling or lacking, although they also mediate attachment to human cells in
tissue culture. Possible exceptions are CS17 LT-only strains that evoked diarrhea in challenged
volunteers [12] and LT-only isolates encoding CS7 that were incriminated in small cohort
studies of pediatric diarrhea [13,14]. While minor CF antigens CS7, CS12, CS14, CS17, CS18,
CS19, CS20, CS21 and CS30 have received most attention, others have also been described
including CS8, CS10, CS11, CS13, CS15 and CS23 [15–19].
DNA-based high-throughput diagnostics have enabled large epidemiologic studies to quan-
tify the ETEC disease burden among young children in developing countries and to assess the
prevalence of various CFs. The overall objective of the Global Enteric Multicenter Study
(GEMS) was to estimate the population-based burden, microbiologic etiology and adverse
clinical consequences of moderate-to-severe diarrhea among children 0–59 months of age in
ETEC colonization factors from a global diarrhea study
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007037 January 4, 2019 3 / 27
study sites in sub-Saharan Africa and South Asia to guide the development and implementa-
tion of vaccines and other interventions [1]. GEMS tested for a large number of diarrheal path-
ogens, including ETEC, among cases of moderate-to-severe diarrhea (MSD) and matched (by
age, gender, neighborhood and time of presentation) control children without diarrhea in
three age strata (0–11, 12–23 and 24–59 months) at four sites in sub-Saharan Africa and three
in South Asia [1,20], the geographic regions where 80% of global diarrheal deaths occur. The
main underlying assumption of GEMS was that a limited number of etiologic agents may be
responsible for a disproportionately large fraction of all MSD [21]. ST-producing ETEC, i.e.,
LT/ST and ST-only strains, were significantly incriminated as pathogens and placed ETEC as
one of the top four pathogens associated with MSD across all seven sites and age groups [1].
A secondary aim of GEMS was to elucidate the proportion of ETEC strains, by toxin geno-
type that encode the main CFs and selected minor CFs. Herein we present the proportion of
GEMS ETEC isolates that encode the main CFs found in most ETEC vaccines under develop-
ment, and the prevalence of ten other putative attachment factors (CS7, CS12, CS13, CS14,
CS17, CS18, CS19, CS20, CS21, CS30) that have been proposed as potential antigens to
broaden ETEC vaccine immunoprophylaxis. In addition, based on the GEMS case/control
design, we utilized conditional logistic regression to assess the strength of association with
MSD of ETEC of the different toxin genotypes encoding the major and minor CFs.
Methods
Study design and population
The rationale [20], assumptions, clinical, epidemiological and microbiological methods of
GEMS [1,22], a three-year case-control study undertaken among children <5 years of age in
Gambia (Basse), Mali (Bamako), Mozambique (Manhic¸a) and Kenya (Siaya County) in sub-
Saharan Africa and India (Kolkata), Bangladesh (Mirzapur) and Pakistan (Karachi-Bin Qasim
Town) in South Asia, have been described. MSD was defined as an acute episode of diarrhea
(�3 loose stools during a 24-hour period) that started within the previous seven days, was sep-
arated from another episode by�7 days, and was accompanied by either signs of dehydration
(sunken eyes, slow abdominal “skin pinch” recoil or administration of intravenous fluids), dys-
entery or admission to hospital based on clinical concern over diarrheal disease severity [1,23].
The current GEMS report includes a descriptive summary of the prevalence of CFs among
ETEC isolates from cases and controls by toxin profile and country, followed by analyses that
utilize the GEMS matched case-control design to test hypotheses that major or minor CFs
might be significantly related to the risk of MSD. Collectively, this information can help guide
ETEC vaccine developers.
Ethics
This research involved characterization of isolates of enterotoxigenic Escherichia coli obtained
from participants in the Global Enteric Multicenter Study (GEMS). The ethical review meth-
ods for this study were described in detail [23], as well as summarized in the overall publication
of the results of the clinical study "The clinical protocol was approved by ethics committees at
the University of Maryland, Baltimore, MD, USA, and at every field site [1]. Written informed
consent was obtained from the parent or primary caretaker of each participant before initia-
tion of study activities [1].” The clinical protocol included the collection of stool specimens or
rectal swabs that were tested for the presence of colonies of enterotoxigenic E. coli and for the
presence of other enteric pathogens [1,22].
ETEC colonization factors from a global diarrhea study
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Procedures
Stools/rectal swabs from cases and controls were cultured onto MacConkey and xylose/lysine/
deoxycholate agar and three E. coli colonies per subject were identified and pooled for extrac-
tion of DNA which was then tested by a multiplex PCR containing primers to amplify eltB (LT
B subunit) and est (ST) [22]. ETEC strains were shipped to the University of Chile and con-
firmed by PCR to detect LT and ST variants (STh and STp) [24,25]. Confirmed ETEC isolates
were further tested by monoplex or multiplex PCRs using primers that detect target genes
encoding the major CFs (CFA/I, CFA/II [CS1, CS2, CS3], CFA/IV [CS4, CS5, CS6])
[16,24,26,27] and various minor CFs (CS7, CS12, CS13, CS14, CS17, CS18, CS19, CS20, CS21,
CS30) (Table 1) [16–19,28].
The rationale for selecting some of the minor CFs for testing was because epidemiologic
data incriminate them as being associated with pediatric diarrhea (e.g., LT-only strains
expressing CS7) [13,14]. We tested for other minor CFs because volunteer challenges with well
characterized strains encoding them showed that they can elicit diarrhea (e.g., CS17 and CS19)
[29]. CS14 was studied because it has been common among ST-only and LT/ST ETEC in vari-
ous reports [30,31]. CS18 and CS20 were studied because they share high homology. CS12 and
CS21 (“longus”) were studied because of long-term interest of some GEMS investigators [32–
34], and their global prevalence [30], and advocates contending that they are virulence attri-
butes [35]. CS30 was studied because it is found in LT/STp isolates and has homology to CS18
and CS20 [19].
We also selected the cited minor CFs to be studied based on their genetic relationships
within the usher genomic typing system [36–38]. The majority of ETEC CFs are synthesized
and transported utilizing a chaperone-usher system that typically contains four genes encoding
a periplasmic chaperone, a major fimbrial subunit, an outer membrane usher and a minor sub-
unit tip adhesin. Since there is only a single usher gene among these ETEC CFs, they can be
readily classified by their sequences [36–38]. All the major CFs except CS3 and CS6 are found
within the α usher sequence group, including CFA/I, CS1, CS2, CS4 and CS5. Minor CFs in
this α group include CS7, CS14, CS17 and CS19; these homologies were another reason we
tested for these CFs among the GEMS ETEC isolates. The γ2 usher family includes four minor
CFs of interest, CS12, CS18, CS20 and CS30, which is partly why we tested for them. CS13
belongs to the κ group [37]. CS3 and CS6 major CFs reside within the γ3 usher group. CS8
(previously called CFA/III), which was not studied, and CS21 are not classifiable within the
chaperone-usher system, since they are synthesized as type IVb pili.
CS18 and CS20 were initially tested using previously described primers that amplify
sequences within fotG (which encodes the tip adhesin of CS18) [25], and csnA (which encodes
the major subunit of CS20) [27]. With the recent report of CS30, a new minor colonization fac-
tor (CF) [19], and revelation of its similarity to CS18 and CS20, new primers were designed to
enhance specificity. The new primers to detect CS18 amplify a sequence within fotA (that
encodes the major fimbrial subunit) rather than fotG. Alignments of major and minor struc-
tural subunit genes of CS18, CS20 and CS30 are shown in Figs 1 & 2. Reference strains served
as positive controls [16].
All isolates from the 806 cases and 711 control participants whose cultures yielded ETEC
isolates were also tested by polymerase chain reaction (PCR) for genes encoding CFA/I and
CS1-CS6, the major colonization factors (CFs). In addition, these isolates were all tested by
PCR for several minor CFs including CS7, CS12, CS14, CS17 and CS21, all of which had been
proposed to be potential virulence attributes and potential antigens to be included in an ETEC
vaccine intending to elicit anti-colonization immunity.
ETEC colonization factors from a global diarrhea study
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Table 1. Primers used in this study for detection of toxin and colonization factor genes in ETEC strains.
Gene (Toxin/CFs) Primer sequence (5’– 3’) Concentration (pmol/uL) PCR type (Mn/Mt) Product size (bp) Reference
eltB (LT) F: GCACACGGAGCTCCTCAGT 0.2 Mn 218 Vidal et al.[24]
R: TCCTTCATCCTTTCAATGGCTTT
sta2 (STh) F: TTCTTTCTGTATTGTCTTTTTCACC 0.2 Mn 193 Vidal et al.[24]
R: TAATAGCACCCGGTACAAGCAG
sta1 (STp) F: CCTCGACATATAACATGATGCAACTC 0.2 Mn 127 This study
R: AAATTGCCAACATTAGCTTTTTCA
sta1 (STp) F: TCTTTCCCCTCTTTTAGTCAG 0.2 Mn 166 Rodas et al.[25]
R: ACAGGCAGGATTACAACAAAG
cfaB (CFA/I) F: ACTATTGGTGCAATGGCTCTGAC 0.2 Mt1 497 Vidal et al.[24]
R: CAGGATCCCAAAGTCATTACAAG
cooA (CS1) F: GAGAAGACCATTAGCGTTACGG 0.16 Mt3 410 Vidal et al.[24]
R: CCCTGATATTGACCAGCTGTTAG
cotA (CS2) F: ACTGTAACTGCTAGCGTTGATCC 0.2 Mt1 358 Vidal et al.[24]
R: TGCTTCCTGCATTAATAACGAGT
cstH (CS3) F: CCCACTCTAACCAAAGAACTGG 0.48 Mt3 300 Vidal et al.[24]
R: CGTATTTCCAGCATTTTTATCCA
csaB (CS4) F: ATTGATATTTTGCAAGCTGATGG 0.32 Mt3 242 Vidal et al.[24]
R: GTCACATCTGCGGTTGATAGAGT
csfA (CS5) F: TCCGCTCCCGTTACTCAG 0.2 Mt2 226 Sjo¨ling et al.[27]
R: GAAAAGCGTTCACACTGTTTATATT
cssA (CS6) F: AAATGTATCCCAGGTAACGGTCT 0.2 Mt2 165 Vidal et al.[24]
R: TGTTGATTAGGCGTAACCTCTGT
csvA (CS7) F: TGCTCCCGTTACTAAAAATAC 0.16 Mt4 203 Del Canto et al.[16]
R: TAGATGTCGTATCACTACGT
cswA (CS12) F: GCGAATAACAATGATGCAAG 0.16 Mt4 263 Del Canto et al.[16]
R: CCTGACTGGTTTACAAGATA
cshE (CS13) F: GGGACTGCCACAATGAATTT 0.4 Mn 178 Sjo¨ling et al.[27]
R: CAGCACCACCTGCTGATTTA
csuA1 (CS14) F: TTTGCAACCGACATCTACCA 0.4 Mn 162 Sjo¨ling et al.[27]
R: CCGGATGTAGTTGCTCCAAT
csbA-csdA (CS17-19) F: TAAACTTGATCTTCTGCAAGC 0.16 Mt4 348 Del Canto et al.[16]
R: GCATGAATCGTAAGCTGTTG
csbA (CS17) F: TAAACTTGATCTTCTGCAAGC 0.16 Mn 324 Del Canto et al.[16]
R: TCAGGCGCAGTTCCTTGTGTG
fotG (CS18) F: ATCCGTCAGGTGTTTGTGGT 0.4 Mn 362 Rodas et al.[25]
R: CACCTGAATTCCTCGACAGG
csnA (CS20) F: AGGTATCCAAATCCGCACTG 0.4 Mn 114 Sjo¨ling et al.[27]
R: CATCAGCCAGCACATAGGAA
fotA (CS18) F: TGGTGTAGGTGTGTTTGTCC 0.2 Mn 193 This study
R: AGTACCAGCTTTAACCTGACC
csnA (CS20) F: CCTGATTAACTGTGACAGCCT 0.2 Mn 189 This study
R: ACAACGTCAAGTTTTTGATCGC
lngA (CS21) F: TCATGAGCCTGCTGGAAGTTATCA 0.16 Mn 617 Pichel et al.[28]
R: TCCGGCTACCTAAAGTAATTGAGT
csmA (CS30) F: AGTCAGCTCTTGCAGCCAGT 0.2 Mn 219 von Mentzer et al.[19]
(Continued)
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ETEC isolates from cases (N = 203) and controls (N = 295) that were negative for the major
CFs and for minor CFs CS7, CS12, CS14, CS17 and CS21 were tested for genes encoding sev-
eral additional minor CFs including CS13, CS18, CS19 and CS20; isolates from nine cases and
eight controls could not be tested because they were not recoverable. After completion of test-
ing for CS13, CS18, CS19 and CS20, a new minor CF, CS30, was reported as being found
among a proportion of LT/ST isolates [19]. We thereupon re-tested for CS30 the 113 LT/ST
isolates that were among the above-mentioned 203 case isolates; the 65 LT/ST isolates among
the above-mentioned 295 control isolates were also tested. However, because of sequence
homologies among CS30, CS18 and CS20, we also re-tested the 65 case and 113 control isolates
for CS18 and CS20 using new primers that were designed to increase specificity (vide supra)
(Figs 1 & 2).
Crude bacterial lysate was obtained by boiling five pooled colonies of each ETEC isolate in
0�1% Triton X-100 for 10 min, followed by centrifugation at 8000×g for five minutes to sepa-
rate template DNA in the supernatant from cellular debris. PCR was performed with total bac-
terial DNA in a 25-μL reaction, containing 10 mmol/L deoxyribonucleotide triphosphate mix,
30 mmol/L MgCl2, 1× reaction buffer (10 mmol/L Tris–HCl, 50 mmol/L KCl), one Unit of
Taq polymerase (GoTaq; Promega, Madison, WI), and 1 μL of template DNA. Primers were
used at concentrations shown in Table 1. To prevent nonspecific amplification, we used the
“hot start” technique, which includes preheating reaction mixtures to 94˚C for five minutes
before adding Taq DNA polymerase. Samples were amplified for 35 cycles, with each cycle
comprising 90 seconds at 94˚C for denaturation, 30 seconds at specific primers annealing tem-
peratures, 60 seconds at 68˚C for strand elongation, and a final extension at 72˚C for five min-
utes. PCR products were electrophoresed in 2.0% agarose, stained with ethidium bromide, and
amplicons identified based on expected size of the amplified product compared with ampli-
cons of reference strains.
A subset of ETEC isolates were sent to the WHO Enterotoxigenic Escherichia coli Reference
Laboratory, University of Gothenburg, Sweden, where they were tested for STp, STh, major
CFs and phenotypic expression of CFs using monoclonal antibodies [27]. Gothenburg primers
for STp and CS5 were used in Chile in addition to local primers [16,24,25,27].
Data analysis
Presentation of the descriptive observational data and analyses were restricted to ETEC cases
that had a single ETEC toxin/CF genotype pattern.
Descriptive data. Prevalences of ETEC CFs were expressed as percentages in a stratified
manner by ETEC toxin profile, site and region.
Matched case-control studies of the associations between ETEC CFs and MSD. Analy-
ses of the strength of association between ETEC toxin and CF genotypes and MSD were per-
formed using conditional logistic regression models in which the outcome was case-control
status (MSD) and the independent variable (covariate) was whether the child’s ETEC had the
specific CFA (no/yes) [39], while applying Firth’s penalized likelihood approach [40]. Use of
Table 1. (Continued)
Gene (Toxin/CFs) Primer sequence (5’– 3’) Concentration (pmol/uL) PCR type (Mn/Mt) Product size (bp) Reference
R: CCTTGGTACCATTGCTGGTT
CFs: Colonization Factors Mn: Monoplex PCR Mt: Multiplex-PCR. The numbers associated with each Mt correspond to the primers associated with each multiplex
reaction.
https://doi.org/10.1371/journal.pntd.0007037.t001
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conditional logistic regression was dictated by the matched case/control design, while the Firth
approach was indicated because the subset of ETEC cases and ETEC controls that encode CFs
is relatively small compared to the total number of children with ETEC infection. Matched
odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were obtained from these
models. Because pooled as well as site-specific analyses were conducted, we examined for het-
erogeneity in ORs across sites using Chi square test for heterogeneity. A p�0.05 was consid-
ered significant. We did not use a Bonferroni adjustment for these 19 individual conditional
logistic regression analyses of the association of individual minor CFs with MSD, as in each
instance an individual hypothesis was tested [41–44]. Data were analyzed using SPSS version
23 (IBM, Inc., Armonk, NY) and SAS statistical software version 9.4 (SAS Institute Inc. Cay,
NC, USA).
Fig 1. Alignments of the major structural subunit genes fotA (CS18), csnA (CS20) and csmA (CS30). Primer target sequences CS18-F2 and CS18-R2
are highlighted in light grey. Primer target sequences CS20-F and CS20-R are shown in bold. Primer target sequences CS20-F2 and CS20-R2 are shown
in bold italics. Primer target sequences for-csmA and rev-csmA are highlighted in light grey and underlined.
https://doi.org/10.1371/journal.pntd.0007037.g001
Fig 2. Minor structural subunit genes fotG (CS18), csnG (CS20) and csmG (CS30). Primers CS18-F and CS18-R that allow detection of fotG are highlighted
in light grey.
https://doi.org/10.1371/journal.pntd.0007037.g002
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Results
When tested in a standardized manner in GEMS field-site laboratories using a multiplex PCR
that included primers to detect genes encoding STh and LT [22], colonies from 1067 of 9439
MSD cases (11.3%) and from 975 of 13,129 matched control subjects (7.4%) tested positive.
ETEC isolates were sent to the GEMS Reference Laboratory at the University of Chile to detect
CFs [26]. Upon arrival, all isolates were re-tested to detect LT, STh and STp genes, since upon
storage, sub-culture or transport, ETEC isolates may lose toxin or CF genes [45–48]. E. coli iso-
lates from 894 of the 1067 cases were confirmed as ETEC and among the triplets of isolates
tested from each case, 806 cases (90.2%) had a single toxin/CF profile observed; 83 others
(9.6%) had two profiles and five cases (0.6%) had three different profiles recorded. A single
toxin/CF profile was found among triplets of 711 controls.
Toxin genotypes among ETEC isolates from MSD cases and controls
Among the 806 single toxin/CF profile cases and 711 controls, the percentages of children at
each site who harbored ETEC isolates of the different enterotoxin genotypes are shown in
Table 2, revealing the relative frequency of LT-only, STh-only, STp-only, LT/STh, and LT/STp
infections.
Overall, 68.2% of isolates from cases (N = 550) were either ST-only (N = 291, 36.1%) or LT/
ST (N = 259, 32.1%), the genotypes strongly associated with MSD in GEMS [1]. STh-only
strains were isolated from 284 (35.2%) of 806 cases. The remaining case isolates (N = 256,
31.8%) were LT-only.
Major CFs among ETEC from MSD cases and controls
The proportion of ETEC strains from MSD cases that carry major CF antigens including CFA/
I and CS1-CS6, by toxin genotype, are shown by country (Table 3) and summarized by conti-
nent (Fig 3).
Table 2. Toxin profile of ETEC isolates from cases and from controls by continent and across all seven GEMS sites combined.
Africa Asia Asia & Africa
Toxin Profile Cases
(N = 510)
Controls
(N = 480)
Cases
(N = 296)
Controls
(N = 231)
Cases
(N = 806)
Controls
(N = 711)
LT-only 171 (33.5%)� 249 (51.9%)+ 85 (28.7%)# 84 (36.4%)$ 256 (31.8%) 333 (46.8%)
Any ST-only 182 (35.7%)� 98 (20.4%)+ 109 (36.8%)# 48 (20.8%)$ 291 (36.1%) 146 (20.5%)
STh-only 177 (34.7%)� 94 (19.6%)+ 107 (36.1%)# 40 (17.3)$ 284 (35.2%) 134 (18.8%)
STp-only 5 (1.0%)� 4 (0.8%)+ 2 (0.7%)# 7 (3.0%)$ 7 (0.9%) 11 (1.5%)
STh/STp 0 (0%)� 0 (0%)+ 0 (0%)# 1 (0.4%)$ 0 (0%) 1 (0.1%)
All LT/ST 157 (30.8%)� 133 (27.7%)+ 102 (34.5%)# 99 (42.9%)$ 259 (32.1%) 232 (32.6%)
LT/STh 104 (20.4%)� 65 (13.5%)+ 74 (25.0%)# 30 (13.0%)$ 178 (22.1%) 95 (13.4%)
LT/STp 53 (10.4%)� 67 (14.0%)+ 27 (9.1%)# 69 (29.9%)$ 80 (9.9%) 136 (19.1%)
LT/STh/STp 0 (0%)� 1 (0.2%)+ 1 (0.3%)# 0 (0%)$ 1 (0.1%) 1 (0.1%)
All ST-only + all LT/ST 339 (66.5%)� 231 (48.1%)+ 211 (71.3%)# 147 (63.6%)$ 550 (68.2%) 378 (53.2%)
Data presented are the number of ETEC strains (and percentages) with the indicated toxin profile
� Percent of 510
+ Percent of 480
# percent of 296
$ Percent of 231
https://doi.org/10.1371/journal.pntd.0007037.t002
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Table 3. The prevalence of major colonization factors that are contained in leading vaccine candidates, by toxin profiles, among ETEC strains from 806 MSD cases
from individual GEMS sites in Africa and Asia.
Site Toxin
profile
Total
cases
CFA/I Any CFA/IIa CS3-only CS1+CS3 CS2+CS3 Any CFA/
IVb
CS6-only CS4+CS6 CS5+CS6
Gambia LT-only 35 0/35 (0%) 1/35 (2.9%) 0/35 (0%) 0/35 (0%) 1/35 (2.9%) 7/35 (20.0%) 5/35 (14.3%) 0/35 (0%) 2/35 (5.7%)
ST-only 46 16/46
(34.8%)
0/46 (0%) 0/46 (0%) 0/46 (0%) 0/46 (0%) 17/46
(37.0%)
2/46 (4.3%) 0/46 (0%) 15/46
(32.6%)
LT/ST 39 0/39 (0%) 14/39
(35.9%)
6/39
(15.4%)
1/39
(2.6%)
7/39
(17.9%)
14/39
(35.9%)
4/39 (10.3%) 0/39 (0%) 10/39
(25.6%)
ST+LT/ST 85 16/85
(18.8%)
14/85
(16.5%)
6/85 (7.1%) 1/85
(1.2%)
7/85 (8.2%) 31/85
(36.5%)
6/85 (7.1%) 0/85 (0%) 25/85
(29.4%)
Mali LT-only 51 1/51 (2.0%) 0/51 (0%) 0/51 (0%) 0/51 (0%) 0/51 (0%) 15/51
(29.4%)
14/51
(27.5%)
0/51 (0%) 1/51 (2.0%)
ST-only 46 17/46
(37.0%)
0/46 (0%) 0/46 (0%) 0/46 (0%) 0/46 (0%) 20/46
(43.5%)
4/46 (8.7%) 0/46 (0%) 16/46
(34.8%)
LT/ST 41 4/41 (9.8%) 6/41
(14.6%)
1/41 (2.4%) 1/41
(2.4%)
4/41 (9.8%) 12/41
(29.3%)
1/41 (2.4%) 3/41
(7.3%)
8/41 (19.5%)
ST+LT/ST 87 21/87
(24.1%)
6/87 (6.9%) 1/87 (1.1%) 1/87
(1.1%)
4/87 (4.6%) 32/87
(36.8%)
5/87 (5.7%) 3/87
(3.4%)
24/87
(27.6%)
Mozambique LT-only 16 0/16 (0%) 0/16 (0%) 0/16 (0%) 0/16 (0%) 0/16 (0%) 4/16 (25.0%) 1/16 (6.3%) 0/16 (0%) 3/16 (18.8%)
ST-only 22 9/22 (40.9%) 0/22 (0%) 0/22 (0%) 0/22 (0%) 0/22 (0%) 4/22 (18.2%) 2/22 (9.1%) 0/22 (0%) 2/22 (9.1%)
LT/ST 25 0/25 (0%) 8/25
(32.0%)
1/25 (4.0%) 2/25
(8.0%)
5/25
(20.0%)
13/25
(52.0%)
1/25 (4.0%) 0/25 (0%) 12/25
(48.0%)
ST+LT/ST 47 9/47 (19.1%) 8/47
(17.0%)
1/47 (2.1%) 2/47
(4.3%)
5/47
(10.6%)
17/47
(36.2%)
3/47 (6.4%) 0/47 (0%) 14/47
(29.8%)
Kenya LT-only 69 0/69 (0%) 0/69 (0%) 0/69 (0%) 0/69 (0%) 0/69 (0%) 16/69
(23.2%)
11/69
(15.9%)
0/69 (0%) 5/69 (7.2%)
ST-only 68 24/68
(35.3%)
0/68 (0%) 0/68 (0%) 0/68 (0%) 0/68 (0%) 13/68
(19.1%)
3/68 (4.4%) 0/68 (0%) 10/68
(14.7%)
LT/ST 52 2/52 (3.8%) 18/52
(34.6%)
2/52 (3.8%) 9/52
(17.3%)
7/52
(13.5%)
14/52
(26.9%)
2/52 (3.8%) 1/52
(1.9%)
11/52
(21.2%)
ST+LT/ST 120 26/120
(21.7%)
18/120
(15.0%)
2/120
(1.7%)
9/120
(7.5%)
7/120
(5.8%)
27/120
(22.5%)
5/120 (4.2%) 1/120
(0.8%)
21/120
(17.5%)
Africa LT-only 171 1/171
(0.6%)
1/171
(0.6%)
0/171 (0%) 0/171 (0%) 1/171
(0.6%)
42/171
(24.6%)
31/171
(18.1%)
0/171
(0%)
11/171
(6.4%)
ST-only 182 66/182
(36.3%)
0/182 (0%) 0/182 (0%) 0/182 (0%) 0/182 (0%) 54/182
(29.7%)
11/182
(6.0%)
0/182
(0%)
43/182
(23.6%)
LT/ST 157 6/157
(3.8%)
46/157
(29.3%)
10/157
(6.4%)
13/157
(8.3%)
23/157
(14.6%)
53/157
(33.8%)
8/157
(5.1%)
4/157
(2.5%)
41/157
(26.1%)
ST+LT/ST 339 72/339
(21.2%)
46/339
(13.6%)
10/339
(2.9%)
13/339
(3.8%)
23/339
(6.8%)
107/339
(31.6%)
19/339
(5.6%)
4/339
(1.2%)
84/339
(24.8%)
India LT-only 26 0/26 (0%) 0/26 (0%) 0/26 (0%) 0/26 (0%) 0/26 (0%) 8/26 (30.8%) 5/26 (19.2%) 0/26 (0%) 3/26 (11.5%)
ST-only 36 13/36
(36.1%)
0/36 (0%) 0/36 (0%) 0/36 (0%) 0/36 (0%) 8/36 (22.2%) 4/36 (11.1%) 1/36
(2.8%)
3/36 (8.3%)
LT/ST 44 3/44 (6.8%) 19/44
(43.2%)
6/44
(13.6%)
6/44
(13.6%)
7/44
(15.9%)
13/44
(29.5%)
1/44 (2.3%) 0/44 (0%) 12/44
(27.3%)
ST+LT/ST 80 16/80
(20.0%)
19/80
(23.8%)
6/80 (7.5%) 6/80
(7.5%)
7/80 (8.8%) 21/80
(26.3%)
5/80 (6.3%) 1/80
(1.3%)
15/80
(18.8%)
Bangladesh LT-only 17 0/17 (0%) 0/17 (0%) 0/17 (0%) 0/17 (0%) 0/17 (0%) 2/17 (11.8%) 1/17 (5.9%) 0/17 (0%) 1/17 (5.9%)
ST-only 15 5/15 (33.3%) 1/15 (6.7%) 0/15 (0%) 0/15 (0%) 1/15 (6.7%) 5/15 (33.3%) 4/15 (26.7%) 0/15 (0%) 1/15 (6.7%)
LT/ST 24 1/24 (4.2%) 5/24
(20.8%)
0/24 (0%) 3/24
(12.5%)
2/24 (8.3%) 7/24 (29.2%) 1/24 (4.2%) 0/24 (0%) 6/24 (25.0%)
ST+LT/ST 39 6/39 (15.4%) 6/39
(15.4%)
0/39 (0%) 3/39
(7.7%)
3/39 (7.7%) 12/39
(30.8%)
5/39 (12.8%) 0/39 (0%) 7/39 (17.9%)
(Continued)
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Overall, 363 (66.0%) of 550 ST-only and LT/ST strains encoded a major CF including
20.4% encoding CFA/I, 14.0% encoding CFA/II (i.e., CS3 alone or with CS1 or CS2) and
31.6% encoding CFA/IV (i.e., CS6 alone or with CS4 or CS5). The only major CF commonly
observed among LT-only isolates was CS6-only, recorded in 43 of 256 LT-only strains (16.8%).
Only three of 256 LT-only strains (1.2%) encoded CFA/I or CFA/II.
The 975 putative ETEC strains from control subjects that arrived at the GEMS ETEC Refer-
ence Laboratory at the University of Chile were re-tested to detect LT, STh and STp genes, of
which 748 were confirmed as positive. Table 4 summarizes the proportion of ETEC strains
from controls that encoded the major CF antigens including CFA/I and CS1-CS6, with data
presented by country, continent and toxin genotype. Overall, 170 of 378 ST-only and LT/ST
strains (45.0%) encoded a major CF antigen including 6.9% encoding CFA/I, 15.1% encoding
CFA/II and 23.0% encoding CFA/IV. Among 333 LT-only isolates, one (0.6%) encoded
CS3-only, 63 encoded CS6-only (18.9%), one encoded CS4+CS6 (0.3%) and 29 had CS5+CS6
(8.7%).
Minor CFs among ETEC case isolates lacking major CFs
Recognizing that 34.0% of ST-only and LT/ST strains and 82.0% of LT-only strains do not
encode a major CF, we investigated those isolates to detect ones that encode exclusively one of
Table 3. (Continued)
Site Toxin
profile
Total
cases
CFA/I Any CFA/IIa CS3-only CS1+CS3 CS2+CS3 Any CFA/
IVb
CS6-only CS4+CS6 CS5+CS6
Pakistan LT-only 42 0/42 (0%) 1/42 (2�4%) 0/42 (0%) 1/42
(2.4%)
0/42 (0%) 9/42 (21.4%) 6/42 (14.3%) 0/42 (0%) 3/42 (7.1%)
ST-only 58 17/58
(29.3%)
0/58 (0%) 0/58 (0%) 0/58 (0%) 0/58 (0%) 18/58
(31.0%)
8/58 (13.8%) 2/58
(3.4%)
8/58 (13.8%)
LT/ST 34 1/34 (2.9%) 6/34
(17.6%)
1/34 (2.9%) 0/34 (0%) 5/34
(14.7%)
16/34
(47.1%)
1/34 (2.9%) 1/34
(2.9%)
14/34
(41.2%)
ST+LT/ST 92 18/92
(19.6%)
6/92 (6.5%) 1/92 (1.1%) 0/92 (0%) 5/92 (5.4%) 34/92
(37.0%)
9/92 (9.8%) 3/92
(3.3%)
22/92
(23.9%)
Asia LT-only 85 0/85 (0%) 1/85 (1.2%) 0/85 (0%) 1/85
(1.2%)
0/85 (0%) 19/85
(22.4%)
12/85
(14.1%)
0/85 (0%) 7/85 (8.2%)
ST-only 109 35/109
(32.1%)
1/109
(0.9%)
0/109 (0%) 0/109 (0%) 1/109
(0.9%)
31/109
(28.4%)
16/109
(14.7%)
3/109
(2.8%)
12/109
(11.0%)
LT/ST 102 5/102
(4.9%)
30/102
(29.4%)
7/102
(6.9%)
9/102
(8.8%)
14/102
(13.7%)
36/102
(35.3%)
3/102
(2.9%)
1/102
(1.0%)
32/102
(31.4%)
ST+LT/ST 211 40/211
(19.0%)
31/211
(14.8%)
7/211
(3.3%)
9/211
(4.3%)
15/211
(7.1%)
67/211
(31.8%)
19/211
(9.0%)
4/211
(1.9%)
44/211
(20.9%)
Asia &
Africa
LT-only 256 1/256
(0.4%)
2/256
(0�8%)
0/256 (0%) 1/256
(0.4%)
1/256
(0.4%)
61/256
(23.8%)
43/256
(16.8%)
0/256
(0%)
18/256
(7.0%)
ST-only 291 101/291
(34.7%)
1/291
(0�3%)
0/291 (0%) 0/291 (0%) 1/291
(0.3%)
85/291
(29.2%)
27/291
(9.3%)
3/291
(1.0%)
55/291
(18.9%)
LT/ST 259 11/259
(4.2%)
76/259
(29.3%)
17/259
(6.6%)
22/259
(8.5%)
37/259
(14.3%)
89/259
(34.4%)
11/259
(4.2%)
5/259
(1.9%)
73/259
(28.2%)
ST+LT/ST 550 112/550
(20.4%)
77 /550
(14.0%)
17/550
(3.1%)
22/550
(4.0%)
38/550
(6.9%)
174/550
(31.6%)
38/550
(6.9%)
8/550
(1.5%)
128/550
(23.3%)
a CFA/II strains are defined as encoding CS3 either alone or in combination with either CS1 or CS2 but never both CS1 and CS2. Very rarely isolates that encode CS1
without CS3 have been reported.[26] The rare CFs of this nature recovered in GEMS are not included in this table.
b CFA/IV strains are defined as encoding CS6 either alone or in combination with either CS4 or CS5, but never both CS4 and CS5. Very rarely isolates that encode CS5
without CS6 have been reported. The few such isolates recovered in GEMS are not included in this table.
https://doi.org/10.1371/journal.pntd.0007037.t003
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the following characterized minor CF antigens: CS7, CS12, CS13, CS14, CS17, CS18, CS19,
CS20, CS21 or CS30. We determined the proportion of ETEC MSD cases that had isolates
encoding one of these minor CFs in the absence of a major CF and that accounted for at least
5.0% of the overall case isolates of that toxin genotype (Table 5).
Among MSD cases with ST-only ETEC, only CS14, identified in 58 ST-only cases (19.9%),
reached a prevalence of�5% (Table 5); four MSD cases with LT/ST isolates lacking major CFs
also encoded solely CS14 (1.5%). Cases isolates having other minor CS antigens encoded as the
sole CS were uncommon (<5%) among ST-only and LT/ST isolates. As an example, we cite
recently described CS30 [19]. Among the 83 LT/ST cases whose isolates lacked major CFs, 16,
all LT/STp genotype, encoded CS30 but only five cases had CS30 as the sole CS. The 192 MSD
cases with LT-only isolates lacking major CFs included strains encoding CS7 (7.8%) or CS17
(6.6%) as sole CS antigens, yielding a cumulative prevalence of 14.4% for LT-only strains
encoding one of those two minor CFs (Table 5).
Conditional logistic regression analyses to assess the strength of association
between CF-toxin genotypes and MSD
The GEMS case/control design allowed us to assess the strength of association between the
various major and minor CFs and MSD among cases versus their matched controls using con-
ditional logistic regression models. To document the validity of this methodology, we first
quantified the strength of association with MSD of the major CFs (Table 6), since they are
widely regarded as true virulence attributes. ST-only and LT/ST strains encoding CFA/I, CFA/
II and CFA/IV were all significantly associated with MSD (p<0.0001, p = 0.006, p<0.0001,
respectively). In contrast, LT-only strains encoding only CS6 or CS5 and CS6 were not signifi-
cantly associated with MSD (p>0.05; Table 6).
Conditional logistic regression modeling was then performed to assess the association
between LT/ST and ST-only ETEC expressing one of the 10 minor CFs alone (CS7, CS12,
CS13, CS14, CS17, CS18, CS19, CS20, CS21 or CS30) and MSD. Among ST-only and LT/ST
ETEC strains encoding exclusively a single minor CF but no major CF, only CS14 was signifi-
cantly associated with MSD (Table 6).
When conditional logistic regression was performed for LT-only cases and ETEC strains
encoding exclusively one of these ten minor CFs, only CS21 exhibited a significant association
(p = 0.028). However, LT-only isolates expressing CS21 exclusively were uncommon among
cases (N = 4) and matched controls (N = 0). CS7 did not show a significant association
(p = 0.071) but the sample sizes of cases (N = 20) and controls (N = 12) were small. We did not
use a Bonferroni adjustment for these individual conditional logistic regression analyses of the
association of individual minor CFs with MSD, as in each instance an individual hypothesis
was being tested [41–44].
Phenotypic expression of CFs
ETEC isolates from 443 cases (338 encoding major CFs and 105 encoding a single minor CF)
were tested by dot blot immunoassay with specific anti-CF antibodies to determine the percent
that phenotypically expressed on their bacterial surface the encoded major CF antigens. Of
ETEC encoding CFA/I or CS1-CS5, 73.8–95.1% of isolates tested were dot blot-positive
(Table 7); the exceptions were the 65 CS6-only isolates tested that showed only 38.5%
Fig 3. The prevalence of ETEC isolates from cases of moderate-to-severe diarrhea encoding both LT and ST enterotoxins (blue), ST-
only (yellow) or LT-only (blue) and also encoding the major colonization factors CFA/I, CFA/II or CFA/IV. Data from the four
African, three Asian and all sites are shown.
https://doi.org/10.1371/journal.pntd.0007037.g003
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Table 4. The prevalence of major colonization factors that are contained in leading vaccine candidates, by toxin profiles, among ETEC strains from 711 control sub-
jects from GEMS sites in Africa and Asia.
Site Toxin
profile
Total
controls
CFA/I Any CFA/
IIa
CS3-only CS1+CS3 CS2+CS3 Any CFA/
IVb
CS6-only CS4+CS6 CS5+CS6
Gambia LT-only 58 0/58 (0%) 0/58 (0%) 0/58 (0%) 0/58 (0%) 0/58 (0%) 16/58
(27.6%)
12/58
(20.7%)
0/58 (0%) 4/58 (6.9%)
ST-only 33 8/33
(24.2%)
0/33 (0%) 0/33 (0%) 0/33 (0%) 0/33 (0%) 17/33
(51.5%)
12/33
(36.4%)
0/33 (0%) 5/33
(15.2%)
LT/ST 39 0/39 (0%) 10/39
(25.6%)
2/39 (5.1%) 0/39 (0%) 8/39
(20.5%)
8/39
(20.5%)
2/39 (5.1%) 0/39 (0%) 6/39
(15.4%)
ST+LT/ST 72 8/72
(11.1%)
10/72
(13.9%)
2/72 (2.8%) 0/72 (0%) 8/72
(11.1%)
25/72
(34.7%)
14/72
(19.4%)
0/72 (0%) 11/72
(15.3%)
Mali LT-only 49 0/49 (0%) 0/49 (0%) 0/49 (0%) 0/49 (0%) 0/49 (0%) 19/49
(38.8%)
14/49
(28.6%)
1/49
(2.0%)
4/49 (8.2%)
ST-only 22 3/22
(13.6%)
0/22 (0%) 0/22 (0%) 0/22 (0%) 0/22 (0%) 6/22
(27.3%)
1/22 (4.5%) 1/22
(4.5%)
4/22
(18.2%)
LT/ST 26 0/26 (0%) 6/26
(23.1%)
0/26 (0%) 1/26 (3.8%) 5/26
(19.2%)
6/26
(23.1%)
2/26 (7.7%) 0/26 (0%) 4/26
(15.4%)
ST+LT/ST 48 3/48 (6.3%) 6/48
(12.5%)
0/48 (0%) 1/48 (2.1%) 5/48
(10.4%)
12/48
(25.0%)
3/48 (6.3%) 1/48
(2.1%)
8/48
(16.7%)
Mozambique LT-only 65 0/65 (0%) 0/65 (0%) 0/65 (0%) 0/65 (0%) 0/65 (0%) 12/65
(18.5%)
6/65 (9.2%) 0/65 (0%) 6/65 (9.2%)
ST-only 12 0/12 (0%) 0/12 (0%) 0/12 (0%) 0/12 (0%) 0/12 (0%) 2/12
(16.7%)
1/12 (8.3%) 0/12 (0%) 1/12 (8.3%)
LT/ST 25 0/25 (0%) 8/25
(32.0%)
4/25
(16.0%)
0/25 (0%) 4/25
(16.0%)
7/25
(28.0%)
4/25 (16.0%) 0/25 (0%) 3/25
(12.0%)
ST+LT/ST 37 0/37 (0%) 8/37
(21.6%)
4/37
(10.8%)
0/37 (0%) 4/37
(10.8%)
9/37
(24.3%)
5/37 (13.5%) 0/37 (0%) 4/37
(10.8%)
Kenya LT-only 77 0/77 (0%) 0/77 (0%) 0/77 (0%) 0/77 (0%) 0/77 (0%) 20/77
(26.0%)
15/77
(19.5%)
0/77 (0%) 5/77 (6.5%)
ST-only 31 5/31
(16.1%)
0/31 (0%) 0/31 (0%) 0/31 (0%) 0/31 (0%) 8/31
(25.8%)
5/31 (16.1%) 0/31 (0%) 3/31 (9.7%)
LT/ST 43 0/43 (0%) 12/43
(27.9%)
3/43 (7.0%) 1/43 (2.3%) 8/43
(18.6%)
8/43
(18.6%)
3/43 (7.0%) 1/43
(2.3%)
4/43 (9.3%)
ST+LT/ST 74 5/74 (6.8%) 12/74
(16.2%)
3/74 (4.1%) 1/74 (1.4%) 8/74
(10.8%)
16/74
(21.6%)
8/74 (10.8%) 1/74
(1.4%)
7/74 (9.5%)
Africa LT-only 249 0/249 (0%) 0/249 (0%) 0/249 (0%) 0/249 (0%) 0/249 (0%) 67/249
(26.9%)
47/249
(18.9%)
1/249
(0.4%)
19/249
(7.6%)
ST-only 98 16/98
(16.3%)
0/98 (0%) 0/98 (0%) 0/98 (0%) 0/98 (0%) 33/98
(33.7%)
19/98
(19.4%)
1/98
(1.0%)
13/98
(13.3%)
LT/ST 133 0/133 (0%) 36/133
(27.1%)
9/133
(6.8%)
2/133
(1.5%)
25/133
(18.8%)
29/133
(21.8%)
11/133
(8.3%)
1/133
(0.8%)
17/133
(12.8%)
ST+LT/
ST
231 16/231
(6.9%)
36/231
(15.6%)
9/231
(6.8%)
2/231
(0.9%)
25/231
(10.8%)
62/231
(26.8%)
30/231
(13.0%)
2/231
(0.9%)
30/231
(13.0%)
India LT-only 35 0/35 (0%) 1/35 (2.9%) 1/35 (2.9%) 0/35 (0%) 0/35 (0%) 9/35
(25.7%)
7/35 (20.0%) 0/35 (0%) 2/35 (5.7%)
ST-only 15 4/15
(26.7%)
1/15 (6.7%) 0/15 (0%) 0/15 (0%) 1/15 (6.7%) 6/15
(40.0%)
3/15 (20.0%) 0/15 (0%) 3/15
(20.0%)
LT/ST 22 0/22 (0%) 7/22
(31.8%)
2/22 (9.1%) 3/22
(13.6%)
2/22 (9.1%) 2/22 (9.1%) 0/22 (0%) 0/22 (0%) 2/22 (9.1%)
ST+LT/ST 37 4/37
(10.8%)
9/37
(21.6%)
2/37 (5.4%) 3/37 (8.1%) 3/37 (8.1%) 8/37
(21.6%)
3/37 (8.1%) 0/37 (0%) 5/37
(13.5%)
Bangladesh LT-only 25 0/25 (0%) 0/25 (0%) 0/25 (0%) 0/25 (0%) 0/25 (0%) 11/25
(44.0%)
6/25 (24.0%) 0/25 (0%) 5/25
(20.0%)
ST-only 11 2/11
(18.2%)
0/11 (0%) 0/11 (0%) 0/11 (0%) 0/11 (0%) 3/11
(27.3%)
1/11 (9.1%) 0/11 (0%) 2/11
(18.2%)
(Continued)
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positivity. Among ETEC case isolates encoding one of the four minor CFs tested, dot blot
immunoassay positivity ranged from 67.2% for CS17 to 94.4% for CS7.
Discussion
The GEMS case/control study demonstrated that ST-only and LT/ST ETEC, the enterotoxin
genotypes exhibited by circa two-thirds of ETEC isolates from patients, were strongly associ-
ated with MSD [1,49]. Field studies involving small pediatric cohorts prospectively followed
under active household surveillance document that these toxin types are also incriminated as
causing milder diarrhea [13,50,51]. Most LT-only strains are not associated with diarrhea
[1,13,50,52,53], as some descend from LT/ST strains through loss of genes encoding ST and a
CF [3]. Nevertheless, evidence from diarrhea outbreaks in industrialized countries [54], exper-
imental challenges in U.S. volunteers [12,55], and epidemiological studies in developing coun-
tries indicate that a subset of LT-only strains do appear to be bona fide diarrheal pathogens
[13,14], and it would be desirable to prevent diarrhea caused by that subset. The quandary,
heretofore, has been how to identify accessory virulence attributes that distinguish the subset
Table 4. (Continued)
Site Toxin
profile
Total
controls
CFA/I Any CFA/
IIa
CS3-only CS1+CS3 CS2+CS3 Any CFA/
IVb
CS6-only CS4+CS6 CS5+CS6
LT/ST 43 0/43 (0%) 8/43
(18.6%)
0/43 (0%) 4/43 (9.3%) 4/43 (9.3%) 3/43 (7.0%) 2/43 (4.7%) 0/43 (0%) 1/43 (2.3%)
ST+LT/ST 54 2/54 (3.7%) 8/54
(14.8%)
0/54 (0%) 4/54 (7.4%) 4/54 (7.4%) 6/54
(11.1%)
3/54 (5.6%) 0/54 (0%) 3/54 (5.6%)
Pakistan LT-only 24 0/24 (0%) 0/24 (0%) 0/24 (0%) 0/24 (0%) 0/24 (0%) 6/24
(25.0%)
3/24 (12.5%) 0/24 (0%) 3/24
(12.5%)
ST-only 22 4/22
(18.2%)
0/22 (0%) 0/22 (0%) 0/22 (0%) 0/22 (0%) 6/22
(27.3%)
3/22 (13.6%) 1/22
(4.5%)
2/22 (9.1%)
LT/ST 34 0/34 (0%) 5/34
(14.7%)
2/34 (5.9%) 3/34 (8.8%) 0/34 (0%) 5/34
(14.7%)
1/34 (2.9%) 0/34 (0%) 4/34
(11.8%)
ST+LT/ST 56 4/56 (7.1%) 5/56 (8.9%) 2/56 (3.6%) 3/56 (5.4%) 0/56 (0%) 11/56
(19.6%)
4/56 (7.1%) 1/56
(1.8%)
6/56
(10.7%)
Asia LT-only 84 0/84 (0%) 1/84 (1.2%) 1/84 (1.2%) 0/84 (0%) 0/84 (0%) 26/84
(31.0%)
16/84
(19.0%)
0/84 (0%) 10/84
(11.9%)
ST-only 48 10/48
(20.8%)
1/48 (2.1%) 0/48 (0.9%) 0/48 (0%) 1/48 (2.1%) 15/48
(31.3%)
7/48
(14.6%)
1/48
(2.1%)
7/48
(14.6%)
LT/ST 99 0/99 (0%) 20/99
(20.2%)
4/99 (4.0%) 10/99
(10.1%)
6/99 (6.1%) 10/99
(10.1%)
3/99 (3.0%) 0/99 (0%) 7/99 (7.1%)
ST+LT/
ST
147 10/147
(6.8%)
21/147
(14.3%)
4/147
(2.7%)
10/147
(6.8%)
7/147
(4.8%)
25/147
(17.0%)
10/147
(6.8%)
1/147
(0.7%)
14/147
(9.5%)
Asia &
Africa
LT-only 333 0/333 (0%) 1/333
(0.3%)
1/333
(0.3%)
0/333 (0%) 0/333 (0%) 93/333
(27.9%)
63/333
(18.9%)
1/333
(0.3%)
29/333
(8.7%)
ST-only 146 26/146
(17.8%)
1/146
(0.7%)
0/146 (0%) 0/146 (0%) 1/146
(0.7%)
48/146
(32.9%)
26/146
(17.8%)
2/146
(1.4%)
20/146
(13.7%)
LT/ST 232 0/232 (0%) 56/232
(24.1%)
13/232
(5.6%)
12/232
(5.2%)
31/232
(13.4%)
39/232
(16.8%)
14/232
(6.0%)
1/232
(0.4%)
24/232
(10.3%)
ST+LT/
ST
378 26/378
(6.9%)
57/378
(15.1%)
13/378
(3.4%)
12/378
(3.2%)
32/378
(8.5%)
8/378
(23.0%)
40/378
(10.6%)
3/378
(0.8%)
44/378
(11.6%)
a CFA/II strains are defined as encoding CS3 either alone or in combination with either CS1 or CS2 but never both CS1 and CS2. Very rarely isolates that encode CS1
without CS3 have been reported,[26] but the rare CFs of this nature recovered in GEMS are not included in this table.
b CFA/IV strains are defined as encoding CS6 either alone or in combination with either CS4 or CS5, but never both CS4 and CS5. Very rarely isolates that encode CS5
without CS6 have been reported but the few such isolates recovered in GEMS are not included in this table.
https://doi.org/10.1371/journal.pntd.0007037.t004
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Table 6. Odds ratios for association with moderate-to-severe diarrhea of ETEC encoding major or minor coloni-
zation factors in combination with different toxin genotypes.
Cases
N = 9439
Controls
N = 13,129
Pooled matched odds
ratio (95% CI)
p
Value
p value for
heterogeneitya
Major colonization
factors
Toxin type
CFA/I ST-only
+ LT/ST
112
(1.19%)
26 (0.20%) 1.85 (1.52–2.22) <0.0001 0.97
Any CFA/II
familyb1
ST-only
+ LT/ST
77
(0.82%)
57 (0.43%) 1.36 (1.08–1�69) 0.006 0.97
Any CFA/IV
familyb2
ST-only
+ LT/ST
174
(1.84%)
87 (0.66%) 1.62 (1.39–1.88) <0.0001 0.88
CS6-only LT-only 43
(0.46%)
63 (0.48%) 0.95 (0.69–1.25) 0.70 0.89
CS5+CS6 LT-only 18
(0.19%)
28 (0.21%) 0.98 (0.59–1.53) 0.90 0.97
Minor
colonization
factors
CS7 b3,c ST-only
+ LT/ST
1 (0.01%) 1 (0.008%) 1.88 (0.21–6.74) 0.40 0.64
LT-only 20
(0.21%)
12 (0.09%) 1.49 (0.93–2.23) 0.071 0.93
CS12b4,c ST-only
+ LT/ST
9
(0.095%)
27 (0.22%) 0.56 (0.27–1.00) 0.076 0.92
LT-only 5
(0.053%)
5 (0.038%) 1.46 (0.55–3.05) 0.30 0.86
CS13b5,c ST-only
+ LT/ST
2
(0.021%)
3 (0.023%) 1.40 (0.29–4.01) 0.50 0.70
LT-only 4
(0.042%)
30 (0.22%) 0.33 (0.11–0.75) 0.021 0.47
CS14b6,c ST-only
+ LT/ST
62
(0.66%)
33 (0.25%) 1.52 (1.17–1.94) 0.0011 0.72
LT-only 11
(0.12%)
10 (0.08%) 1.19 (0.63–2.03) 0.50 0.57
CS17b7,c ST-only
+ LT/ST
1
(0.011%)
2 (0.015%) 1.06 (0.12–3.82) 0.90 0.78
LT-only 17
(0.18%)
15 (0.11%) 1.24 (0.74–1.93) 0.30 0.78
CS18b8,c ST-only
+ LT/ST
1
(0.011%)
0 (0%) 3.03 (0.34–10.96) 0.17
LT-only 4
(0.042%)
2 (0.015%) 1.57 (0.52–3.49) 0.30 0.82
CS19b9,c ST-only
+ LT/ST
0 (0%) 6 (0.046%) 0.22 (0.002–1.46) 0.28 0.81
LT-only 3
(0.032%)
13
(0.099%)
0.51 (0.14–1.26) 0.21 0.39
CS20b10,c ST-only
+ LT/ST
7
(0.074%)
21 (0.16%) 0.66 (0.29–1.25) 0.25 0�77
LT-only 8
(0.085%)
13
(0.099%)
0.95 (0.44–1.75) 0.80 0.98
CS21b11,c ST-only
+ LT/ST
7
(0.074%)
12
(0.091%)
0.93 (0.41–1.78) 0.80 0.99
LT-only 4
(0.042%)
0 (0%) 2.84 (0.95–6.42) 0.028 0.72
(Continued)
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of LT-only ETEC that can cause diarrhea versus the non-pathogenic LT-only strains. Since
individual E. coli colonies from each GEMS MSD case and their controls were tested for genes
encoding LT and ST, it was possible to examine what major and minor CFs were encoded by
the GEMS LT-only isolates as well as by isolates of the other toxin genotypes.
Four cardinal findings emerged from examining the CF genotypes of the GEMS ETEC iso-
lates. First, GEMS results confirm that ETEC vaccines based on stimulating immune responses
to the major CFs (CFA/I and CS1-6), if highly efficacious in blocking CF-mediated attachment
to enterocytes, could prevent diarrhea caused by up to 66% of the ST-only and LT/ST strains,
the toxin genotypes strongly incriminated as pathogens (Table 5). The fact that ETEC encod-
ing these CFs were observed in a very large study involving multiple representative sites in
sub-Saharan Africa and South Asia validates that ETEC vaccine strategy for the geographic
regions where 80% of young child diarrheal deaths occur worldwide. In contrast, major CFs
were uncommon among LT-only isolates.
Important avenues of ETEC vaccinology research have focused on identifying additional
CFs among ST-only and LT/ST isolates that lack CFA/I, CFA/II and CFA/IV and to identify
minor CFs that might be targets for protective immune responses directed against the subset
of LT-only strains that are pathogenic. Thus, the second cardinal observation is identification
of the proportion of strains in each toxin genotype that lacked a major CF but that exclusively
expressed one minor CF, including either CS7, CS12, CS13, CS14, CS17, CS18, CS19, CS20,
CS21 or CS30. Collectively these minor CFs raised the percent of ST-only cases having a recog-
nized CF from 64.3% (187/291) to 86.3% (251/291) and raised the percent of LT/ST cases hav-
ing a recognized CF from 68.0% (176/259) to 79.9% (207/259) (Table 5). The percent of MSD
cases with LT-only ETEC having a recognized CF similarly rose from 25.0% (64/256) to 54.7%
(140/256).
Table 6. (Continued)
Cases
N = 9439
Controls
N = 13,129
Pooled matched odds
ratio (95% CI)
p
Value
p value for
heterogeneitya
CS30b12,c LT/ST 5
(0.053%)
7 (0.053%) 1.13 (0.42–2.34) 0.70 0.48
a There was no significant heterogeneity across GEMS sites (by chi square test for heterogeneity).
b1 ST and CS3-only was not detected in Bangladesh.
b2 ST and CS4 & SC6-only was not found Gambia, Mozambique and Bangladesh.
b3 ST and CS7-only was restricted to Gambia and India.
b4 LT and CS12-only was not found in Gambia.
b5 ST and CS13-only was not found in Mali, India and Pakistan.
b6 LT and CS14-only was not found in Mali and Bangladesh.
b7 ST and CS17-only was found only in Mozambique, Kenya and Bangladesh.
b8 ST and CS18-only was found only in Gambia; LT and CS18-only was found only in Mali and Kenya.
b9 ST and CS19-only was detected in Kenya, India and Bangladesh; LT and CS19-only was not found Mozambique
and Kenya.
b10 LT and CS20-only was not detected in Bangladesh.
b11 LT and CS21-only was detected only in Kenya and Pakistan.
b12 LT-ST and CS30-only was not found in Bangladesh.
c Excludes strains that co-encoded a major colonization factor such as CFA/I, CFA/II, CFA/IV, and all other minor
colonization factors.
Note—These analyses are based on the entire GEMS dataset. In each conditional logistic regression model the
dependent variable was MSD (cases or controls), while the independent variable was the presence (coded as 1) or
absence (coded as 0) of a specified ETEC CF-toxin profile
https://doi.org/10.1371/journal.pntd.0007037.t006
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Although minor CFs encoded by the different toxin genotypes of ETEC strains collectively
raised the proportion of cases that had a CF target, it was not known if these minor CFs also
identified these strains as being pathogenic, i.e., significantly associated with MSD, as were the
major CFs. Moreover, most individual minor CFs were uncommon, defined as<5% of strains
of a toxin genotype that lacked a major CF. Thus, a third cardinal observation was assessment
of the strength of association between MSD and ETEC encoding the various major and minor
CFs within the different toxin genotypes. These novel analyses (Table 6) revealed that the
major CF families encoded by ST-only or LT/ST strains are significantly associated with MSD
Table 7. ETEC isolates from MSD cases encoding colonization factor (CF) genes detected by PCR and phenotypic
expression as detected by dot blot immunoassay using CF-specific antibodies.
Colonization
factor
Total number of GEMS strains
positive for this CF genotype
Total number of strains tested by
dot blot immunoassay
Phenotypic expression
of CF among PCR-
positive isolatesa (%)
Major CFs
CFA/I
With anti-CFA/Ib
113 81 77/81 (95.1%)
CFA/II
With anti-
CS1b
With anti-
CS3 b
CS1 & CS3 23 19 18/19
(94.7%)
18/19
(94.7%)
With anti-
CS2 b
With anti-
CS3 b
CS2 & CS3 39 30 27/30
(90.0%)
27/30
(90.0%)
- With anti-
CS3
CS3-only 17 15 - 14/15
(93.3%) b
CFA/IV
With anti-
CS4 b
With anti-
CS6 b
CS4 & CS6 8 6 5/6
(83.3%)
5/6 (83.3%)
With anti-
CS5 b
With anti-
CS6 b
CS5 & CS6 146 122 90/122
(73.8%)
90/122
(73.8%)
- With anti-
CS6 b
CS6-only 81 65 - 25/65
(38.5%)
Minor CFs
CS7c 21 18 17/18 (94.4%)
CS12c 14 12 9/12 (75.0%)
CS14c 73 61 41/61 (67.2%)
CS17c 18 14 12/14 (85.7%)
a Number of isolates positive by dot blot immunoassay/total number of PCR-positive isolates tested
b Antibody used in the dot blot immunoassay
c Negative for all other colonization factors. Dot blot immunoassays were performed with the homologous antiserum
https://doi.org/10.1371/journal.pntd.0007037.t007
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(CFA/I and CFA/IV, p<0.0001; CFA/II, p = 0.006). Thus, CFA/I, CFA/II and CFA/IV are not
only surface-exposed targets for effector immune responses, but when expressed by LT/ST and
ST-only ETEC they are markers indicating that these strains are strongly incriminated as diar-
rheal pathogens. In contrast, LT-only isolates encoding CS6 alone or CS5 and CS6 were not
significantly associated with MSD (Table 6), nor was there a trend.
A notable proportion (19.9%) of ST-only isolates encoded CS14 alone, i.e., with no other
minor or major CFs, and these were significantly associated with MSD (p = 0.001) (Table 6).
No other individual minor CF was both common and significantly associated with MSD
among the cases infected with ST-only and LT/ST isolates.
Whereas LT-only strains encoding exclusively CS21 were significantly associated with MSD
(p = 0.021), these strains were distinctly uncommon. LT-only strains encoding exclusively CS7
were prevalent (7.8%, Table 5) but they were not significantly associated with MSD (p = 0.07).
However, the sample sizes of cases (N = 20) and controls (N = 12) with LT-only encoding
exclusively CS7 were small, so further investigation of this CF should be encouraged to explore
the potential role of CS7 for potential inclusion in an ETEC vaccine. Support for this notion
comes from two small infant cohort studies in Guinea-Bissau (N = 200) and Egypt (N = 348)
that assessed the association of ETEC encoding specific CFs with diarrhea using logistic regres-
sion models and reported significant associations of LT-only CS7 with infant diarrhea [13,14].
Since experimental challenge with an LT-only strain encoding CS17 fomented diarrhea in
adult volunteers [12], it was somewhat surprising that LT-only/CS17-only strains were not sig-
nificantly associated with MSD in young children in GEMS. Nevertheless, because CS17 shares
epitopes with CFA/I, CS1 and CS2, and CS7 shares epitopes with CS5, the immune responses
to these major CFs within a vaccine that also contains a LT toxoid to stimulate anti-LT could
collectively confer protection against pathogenic LT-only strains encoding CS17 and CS7 [56].
The fourth key observation is that inclusion of CS14 expands the breadth of vaccine cover-
age against ST-only pathogens, raising it from 64.3% to 84.2% (Table 6). Obviously, antigenic
expansion, particularly if multiple minor CFs beyond CS14 (e.g., CS7, CS17, CS21) were to be
added to a major CF-based ETEC vaccine, would increase the vaccine’s complexity and cost.
Nevertheless, there is precedent for successfully addressing this problem with other bacterial
vaccines. Pneumococcal conjugate vaccines were expanded from 7-valent to 13-valent to allow
broader global coverage, while multivalent meningococcal conjugate vaccines currently
include four separate serogroup conjugates. Some ETEC vaccine strategies, such as attenuated
Shigella live vectors encoding two separate CFs per vector strain, can be adapted relatively eas-
ily to express additional CFs [57].
Another approach to broaden coverage of an ETEC vaccine is based on formulating a mix
of fimbrial tip adhesin proteins [5]. Fimbrial CFs can be classified based on the amino acid
sequence relatedness of their tip adhesin proteins, with several important ETEC CFs falling
into Class 5 fimbriae assembled by the alternate chaperone pathway. Whereas the major fim-
brial subunit proteins that create the stalks of these fimbriae differ substantially from one
another antigenically, their tip adhesin proteins are highly conserved into three sub-classes
[58,59]. Antibody against one adhesin of the subclass cross protects against attachment by
other members. Thus, protection may also be broadened by this strategy. Selecting which tip
adhesins to include in a multivalent vaccine requires knowing the frequency of the CFs among
ETEC globally; so the GEMS data inform this vaccine strategy as well. Another strategy to
broaden ETEC vaccine coverage would include non-fimbrial surface antigens, e.g., EtpA (a
non-fimbrial adhesin) and EatA (a serine protease) [60].
Among ETEC strains encoding a major CF other than CS6 alone or a minor CF, 67.2% -
95.1% of isolates reacted with the specific homologous anti-CF antibody by dot blot immuno-
assay, thereby documenting phenotypic expression. The exceptions were the CS6-only isolates
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of which only 25/65 (38.5%) were dot blot-positive (Table 7) whether they were LT-only iso-
lates encoding CS6-only (10/32, 31.3%) or ST-encoding CS6-only strains (15/33, 45.5%). The
expression of CFs is highly regulated [61–63], with temperature, bile, concentrations of glu-
cose, glutamine and iron, and proximity to epithelial cells all influencing expression [64–67].
Thus, one explanation for lack of expression is that the in vitro growth conditions that we uti-
lized did not induce the regulated biosynthesis of isolates encoding certain CFs. Transcrip-
tional regulators such as CfaD (also called CfaR) and Rns that are members of the AraC family
of transcriptional regulators modulate the expression of CFA/I, CS1, CS2, CS4 and CS5
[61,62,66,68]. In contrast, although certain growth conditions such as temperature modify CS6
expression [67], no specific positive regulator has been identified for CS6 [68–70]. Alterna-
tively, isolates that are PCR-positive but dot blot-negative may have single nucleotide polymor-
phisms, minor mutations in structural or chaperone genes or lower copy number plasmids
that still allow amplification by PCR but may diminish or abrogate expression of the CF
[69,71].
One theoretical limitation of our study is that the PCR primers designed to detect ST at the
field sites were optimized for STh; thus some STp-only isolates may have been missed. LT-STp
strains from cases were not under-estimated in GEMS because all LT-only strains were re-
tested with PCRs individually optimized for STp and STh in the Chilean Reference Laboratory
and upon re-testing only a limited number of LT-only isolates were found to be LT/STp. We
believe that few cases and controls with STp-only were missed. A GEMS follow-on study
detected STp and STh in genomic DNA extracted from whole stool specimens of a subset of
5304 case/matched control pairs using a TaqMan Card-based quantitative real-time PCR
(qPCR) methodology and documented that the ST burden was overwhelmingly attributed to
STh [49]. Optimized detection of STp by qPCR increased the overall ETEC disease burden
estimate by only 15% versus what was recorded using the gel-based PCR methodology at the
field sites [49]. This is similar to the overall difference based on presumed gene loss between
primary isolation and results of re-testing strains following storage and transport to the Refer-
ence Laboratory. Other studies have found that STp-only isolates are uncommon compared to
STh-only when methods sensitive for STp are used [13].
Analyzing the array of CFs among GEMS ETEC isolates has provided important informa-
tion to guide ETEC vaccine development and future deployment. Since ST-only and LT/ST
strains are strongly incriminated as the key ETEC pathogens, a fimbrial-based ETEC vaccine
that included CFA/I, CS1-6 and CS14, if highly efficacious, could theoretically confer protec-
tion against up to ~77% of such ETEC pathogens.
Supporting information
S1 Checklist. STROBE checklist.
(DOC)
S1 File.
(XLSX)
Author Contributions
Conceptualization: Roberto M. Vidal, Khitam Muhsen, Karen L. Kotloff, James P. Nataro,
Myron M. Levine.
Data curation: Roberto M. Vidal, Sharon M. Tennant, Ann-Mari Svennerholm, Byomkesh
Manna, Thandavarayan Ramamurthy, Suman Kanungo, Shahnawaz Ahmed, Farheen
ETEC colonization factors from a global diarrhea study
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007037 January 4, 2019 22 / 27
Quadri, Sozinho Aca´cio, Richard Omore, Eric D. Mintz, Ciara E. O’Reilly, Lynette Y.
Berkeley, Sandra Panchalingam, Felipe Del Canto, Karen L. Kotloff.
Formal analysis: Roberto M. Vidal, Khitam Muhsen, Sharon M. Tennant, Yukun Wu, Tracy
H. Hazen, David A. Rasko, Myron M. Levine.
Funding acquisition: Myron M. Levine.
Investigation: Sharon M. Tennant, Samba O. Sow, Dipika Sur, Anita K. M. Zaidi, Abu S. G.
Faruque, Debasish Saha, Richard Adegbola, Boubou Tamboura, Uma Onwuchekwa, Sha-
hida Qureshi, Anowar Hossain, Sumon K. Das, Martin Antonio, Inacio Mandomando,
Tacilta Nhampossa, John B. Ochieng, Joseph O. Oundo, Sofie Livio, Dilruba Nasrin, Tamer
H. Farag, Halvor Sommerfelt, James P. Nataro, Myron M. Levine.
Methodology: Roberto M. Vidal, Khitam Muhsen, Sharon M. Tennant, Roy M. Robins-
Browne, Myron M. Levine.
Project administration: Myron M. Levine.
Resources: Samba O. Sow, Myron M. Levine.
Supervision: Myron M. Levine.
Validation: Myron M. Levine.
Visualization: Myron M. Levine.
Writing – original draft: Myron M. Levine.
Writing – review & editing: Roberto M. Vidal, Khitam Muhsen, Sharon M. Tennant, Ann-
Mari Svennerholm, Samba O. Sow, Dipika Sur, Anita K. M. Zaidi, Abu S. G. Faruque,
Debasish Saha, Richard Adegbola, M. Jahangir Hossain, Pedro L. Alonso, Robert F. Brei-
man, Quique Bassat, Boubou Tamboura, Doh Sanogo, Uma Onwuchekwa, Byomkesh
Manna, Thandavarayan Ramamurthy, Suman Kanungo, Shahnawaz Ahmed, Shahida Qur-
eshi, Farheen Quadri, Anowar Hossain, Sumon K. Das, Martin Antonio, Inacio Mando-
mando, Tacilta Nhampossa, Sozinho Aca´cio, Richard Omore, John B. Ochieng, Joseph O.
Oundo, Eric D. Mintz, Ciara E. O’Reilly, Lynette Y. Berkeley, Sofie Livio, Sandra Panchalin-
gam, Dilruba Nasrin, Tamer H. Farag, Yukun Wu, Halvor Sommerfelt, Roy M. Robins-
Browne, Felipe Del Canto, Tracy H. Hazen, David A. Rasko, Karen L. Kotloff, James P.
Nataro, Myron M. Levine.
References
1. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, et al. Burden and aetiol-
ogy of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multi-
center Study, GEMS): a prospective, case-control study. Lancet. 2013; 382(9888):209–22. https://doi.
org/10.1016/S0140-6736(13)60844-2 PMID: 23680352
2. Hyams KC, Bourgeois AL, Merrell BR, Rozmahel R, Escamilla J, Thornton SA, et al. Diarrheal disease
during Operation Desert Shield. N Engl J Med. 1991; 325:1423–8. https://doi.org/10.1056/
NEJM199111143252006 PMID: 1656260
3. Levine MM. Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive,
enterohemorrhagic, and enteroadherent. J Infect Dis. 1987; 155:377–89. PMID: 3543152
4. Levine MM, Ristaino P, Marley G, Smyth C, Knutton S, Boedeker E, et al. Coli surface antigens 1 and 3
of colonization factor antigen II- positive enterotoxigenic Escherichia coli: morphology, purification, and
immune responses in humans. Infect Immun. 1984; 44:409–20. PMID: 6370866
5. Sincock SA, Hall ER, Woods CM, O’Dowd A, Poole ST, McVeigh AL, et al. Immunogenicity of a proto-
type enterotoxigenic Escherichia coli adhesin vaccine in mice and nonhuman primates. Vaccine. 2016;
34(2):284–91. https://doi.org/10.1016/j.vaccine.2015.11.017 PMID: 26597148
ETEC colonization factors from a global diarrhea study
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007037 January 4, 2019 23 / 27
6. Lundgren A, Bourgeois L, Carlin N, Clements J, Gustafsson B, Hartford M, et al. Safety and immunoge-
nicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine
administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled
Phase I study. Vaccine. 2014; 32(52):7077–84. https://doi.org/10.1016/j.vaccine.2014.10.069 PMID:
25444830
7. Turner AK, Stephens JC, Beavis JC, Greenwood J, Gewert C, Randall R, et al. Generation and charac-
terization of a live attenuated enterotoxigenic Escherichia coli combination vaccine expressing six colo-
nization factors and heat-labile toxin subunit B. Clin Vaccine Immunol. 2011; 18(12):2128–35. https://
doi.org/10.1128/CVI.05345-11 PMID: 21994355
8. Barry EM, Altboum Z, Losonsky G, Levine MM. Immune responses elicited against multiple enterotoxi-
genic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains. Vac-
cine. 2003; 21(5–6):333–40. PMID: 12531629
9. Duan Q, Lu T, Garcia C, Yanez C, Nandre RM, Sack DA, et al. Co-administered Tag-Less Toxoid
Fusion 3xSTaN12S-mnLTR192G/L211A and CFA/I/II/IV MEFA (Multiepitope Fusion Antigen) Induce
Neutralizing Antibodies to 7 Adhesins (CFA/I, CS1-CS6) and Both Enterotoxins (LT, STa) of Enterotoxi-
genic Escherichia coli (ETEC). Front Microbiol. 2018; 9:1198. https://doi.org/10.3389/fmicb.2018.
01198 eCollection;%2018.:1198. PMID: 29922268
10. Taxt AM, Diaz Y, Aasland R, Clements JD, Nataro JP, Sommerfelt H, et al. Towards Rational Design of
a Toxoid Vaccine against the Heat-Stable Toxin of Escherichia coli. Infect Immun. 2016; 84(4):1239–
49. https://doi.org/10.1128/IAI.01225-15 PMID: 26883587
11. Robbins JB, Schneerson R, Szu SC. Perspective: hypothesis: serum IgG antibody is sufficient to confer
protection against infectious diseases by inactivating the inoculum. J Infect Dis. 1995; 171(6):1387–98.
PMID: 7769272
12. McKenzie R, Porter CK, Cantrell JA, Denearing B, O’Dowd A, Grahek SL, et al. Volunteer challenge
with enterotoxigenic Escherichia coli that express intestinal colonization factor fimbriae CS17 and
CS19. J Infect Dis. 2011; 204(1):60–4. https://doi.org/10.1093/infdis/jir220 PMID: 21628659
13. Steinsland H, Valentiner-Branth P, Perch M, Dias F, Fischer TK, Aaby P, et al. Enterotoxigenic Escheri-
chia coli infections and diarrhea in a cohort of young children in Guinea-Bissau. J Infect Dis. 2002; 186
(12):1740–7. https://doi.org/10.1086/345817 PMID: 12447759
14. Mansour A, Shaheen HI, Amine M, Hassan K, Sanders JW, Riddle MS, et al. Pathogenicity and pheno-
typic characterization of enterotoxigenic Escherichia coli isolates from a birth cohort of children in rural
Egypt. J Clin Microbiol. 2014; 52(2):587–91. https://doi.org/10.1128/JCM.01639-13 PMID: 24478492
15. Gaastra W, Svennerholm AM. Colonization factors of human enterotoxigenic Escherichia coli (ETEC).
Trends Microbiol. 1996; 4(11):444–52. PMID: 8950814
16. del Canto F., Valenzuela P, Cantero L, Bronstein J, Blanco JE, Blanco J, et al. Distribution of classical
and nonclassical virulence genes in enterotoxigenic Escherichia coli isolates from Chilean children and
tRNA gene screening for putative insertion sites for genomic islands. J Clin Microbiol. 2011; 49
(9):3198–203. https://doi.org/10.1128/JCM.02473-10 PMID: 21775541
17. del Canto F., O’Ryan M, Pardo M, Torres A, Gutierrez D, Cadiz L, et al. Chaperone-Usher Pili Loci of
Colonization Factor-Negative Human Enterotoxigenic Escherichia coli. Front Cell Infect Microbiol.
2017; 6:200. https://doi.org/10.3389/fcimb.2016.00200 eCollection;%2016.:200. PMID: 28111618
18. del Canto F., Botkin DJ, Valenzuela P, Popov V, Ruiz-Perez F, Nataro JP, et al. Identification of Coli
Surface Antigen 23, a novel adhesin of enterotoxigenic Escherichia coli. Infect Immun. 2012; 80
(8):2791–801. https://doi.org/10.1128/IAI.00263-12 PMID: 22645287
19. von Mentzer A, Tobias J, Wiklund G, Nordqvist S, Aslett M, Dougan G, et al. Identification and charac-
terization of the novel colonization factor CS30 based on whole genome sequencing in enterotoxigenic
Escherichia coli (ETEC). Sci Rep. 2017; 7(1):12514–743. https://doi.org/10.1038/s41598-017-12743-3
PMID: 28970563
20. Levine MM, Kotloff KL, Nataro JP, Muhsen K. The Global Enteric Multicenter Study (GEMS): Impetus,
Rationale, and Genesis. Clin Infect Dis. 2012; 55 Suppl 4:S215–24. https://doi.org/10.1093/cid/cis761.:
S215-S224.
21. Farag TH, Nasrin D, Wu Y, Muhsen K, Blackwelder WC, Sommerfelt H, et al. Some Epidemiologic, Clin-
ical, Microbiologic, and Organizational Assumptions That Influenced the Design and Performance of
the Global Enteric Multicenter Study (GEMS). Clin Infect Dis. 2012; 55 Suppl 4:S225–31. https://doi.
org/10.1093/cid/cis787.:S225-S231
22. Panchalingam S, Antonio M, Hossain A, Mandomando I, Ochieng B, Oundo J, et al. Diagnostic Microbi-
ologic Methods in the GEMS-1 Case/Control Study. Clin Infect Dis. 2012; 55 Suppl 4:S294–302.
https://doi.org/10.1093/cid/cis754.:S294-S302
23. Kotloff KL, Blackwelder WC, Nasrin D, Nataro JP, Farag TH, van EA, et al. The Global Enteric Multicen-
ter Study (GEMS) of Diarrheal Disease in Infants and Young Children in Developing Countries:
ETEC colonization factors from a global diarrhea study
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007037 January 4, 2019 24 / 27
Epidemiologic and Clinical Methods of the Case/Control Study. Clin Infect Dis. 2012; 55 Suppl 4:S232–
45. https://doi.org/10.1093/cid/cis753.:S232-S245
24. Vidal R, Vidal M, Lagos R, Levine M, Prado V. Multiplex PCR for diagnosis of enteric infections associ-
ated with diarrheagenic Escherichia coli. J Clin Microbiol. 2004; 42(4):1787–9. https://doi.org/10.1128/
JCM.42.4.1787-1789.2004 PMID: 15071051
25. Rodas C, Iniguez V, Qadri F, Wiklund G, Svennerholm AM, Sjoling A. Development of multiplex PCR
assays for detection of enterotoxigenic Escherichia coli colonization factors and toxins. J Clin Microbiol.
2009; 47(4):1218–20. https://doi.org/10.1128/JCM.00316-09 PMID: 19244463
26. Vidal RM, Valenzuela P, Baker K, Lagos R, Esparza M, Livio S, et al. Characterization of the most prev-
alent colonization factor antigens present in Chilean clinical enterotoxigenic Escherichia coli strains
using a new multiplex polymerase chain reaction. Diagn Microbiol Infect Dis. 2009; 65(3):217–23.
https://doi.org/10.1016/j.diagmicrobio.2009.07.005 PMID: 19733027
27. Sjoling A, Wiklund G, Savarino SJ, Cohen DI, Svennerholm AM. Comparative analyses of phenotypic
and genotypic methods for detection of enterotoxigenic Escherichia coli toxins and colonization factors.
J Clin Microbiol. 2007; 45(10):3295–301. https://doi.org/10.1128/JCM.00471-07 PMID: 17687011
28. Pichel MG, Binsztein N, Qadri F, Giron JA. Type IV longus pilus of enterotoxigenic Escherichia coli:
occurrence and association with toxin types and colonization factors among strains isolated in Argen-
tina. J Clin Microbiol. 2002; 40(2):694–7. https://doi.org/10.1128/JCM.40.2.694-697.2002 PMID:
11826000
29. McKenzie R, Porter CK, Cantrell JA, Denearing B, O’Dowd A, Grahek SL, et al. Volunteer challenge
with enterotoxigenic Escherichia coli that express intestinal colonization factor fimbriae CS17 and
CS19. J Infect Dis. 2011; 204(1):60–4. https://doi.org/10.1093/infdis/jir220 PMID: 21628659
30. Qadri F, Svennerholm AM, Faruque AS, Sack RB. Enterotoxigenic Escherichia coli in developing coun-
tries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev. 2005;
18(3):465–83. https://doi.org/10.1128/CMR.18.3.465-483.2005 PMID: 16020685
31. Gonzales L, Sanchez S, Zambrana S, Iniguez V, Wiklund G, Svennerholm AM, et al. Molecular charac-
terization of enterotoxigenic Escherichia coli isolates recovered from children with diarrhea during a 4-
year period (2007 to 2010) in Bolivia. J Clin Microbiol. 2013; 51(4):1219–25. https://doi.org/10.1128/
JCM.02971-12 PMID: 23390275
32. Tacket CO, Maneval DR, Levine MM. Purification, morphology, and genetics of a new fimbrial putative
colonization factor of enterotoxigenic Escherichia coli O159:H4. Infect Immun. 1987; 55:1063–9.
PMID: 2883122
33. Giron JA, Levine MM, Kaper JB. Longus: a long pilus ultrastructure produced by human enterotoxigenic
Escherichia coli. Mol Microbiol. 1994; 12(1):71–82. PMID: 7914665
34. Giron JA, Viboud GI, Sperandio V, Gomez-Duarte OG, Maneval DR, Albert MJ, et al. Prevalence and
association of the longus pilus structural gene (lngA) with colonization factor antigens, enterotoxin
types, and serotypes of enterotoxigenic Escherichia coli. Infect Immun. 1995; 63:4195–8. PMID:
7558343
35. Guevara CP, Luiz WB, Sierra A, Cruz C, Qadri F, Kaushik RS, et al. Enterotoxigenic Escherichia coli
CS21 pilus contributes to adhesion to intestinal cells and to pathogenesis under in vivo conditions.
Microbiology. 2013; 159(Pt 8):1725–35. https://doi.org/10.1099/mic.0.065532-0 PMID: 23760820
36. Nuccio SP, Baumler AJ. Evolution of the chaperone/usher assembly pathway: fimbrial classification
goes Greek. Microbiol Mol Biol Rev. 2007; 71(4):551–75. https://doi.org/10.1128/MMBR.00014-07
PMID: 18063717
37. Madhavan TP, Sakellaris H. Colonization factors of enterotoxigenic Escherichia coli. Adv Appl Micro-
biol. 2015; 90:155–97. https://doi.org/10.1016/bs.aambs.2014.09.003 Epub;%2014 Nov 12.:155–97.
PMID: 25596032
38. Isidean SD, Riddle MS, Savarino SJ, Porter CK. A systematic review of ETEC epidemiology focusing
on colonization factor and toxin expression. Vaccine. 2011; 29(37):6167–78. https://doi.org/10.1016/j.
vaccine.2011.06.084 PMID: 21723899
39. Blackwelder WC, Biswas K, Wu Y, Kotloff KL, Farag TH, Nasrin D, et al. Statistical Methods in the
Global Enteric Multicenter Study (GEMS). Clin Infect Dis. 2012; 55 Suppl 4:S246–53. https://doi.org/
10.1093/cid/cis788.:S246-S253
40. Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993; 80:27–38.
41. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990; 1(1):43–6.
PMID: 2081237
42. Savitz DA, Olshan AF. Multiple comparisons and related issues in the interpretation of epidemiologic
data. Am J Epidemiol. 1995; 142(9):904–8. PMID: 7572970
ETEC colonization factors from a global diarrhea study
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007037 January 4, 2019 25 / 27
43. Savitz DA, Olshan AF. Describing data requires no adjustment for multiple comparisons: a reply from
Savitz and Olshan. Am J Epidemiol. 1998; 147(9):813–4. PMID: 9583710
44. Perneger TV. What’s wrong with Bonferroni adjustments. BMJ. 1998; 316(7139):1236–8. PMID:
9553006
45. Evans DJ Jr., Evans DG, DuPont HL, Orskov F, Orskov. Patterns of loss of enterotoxigenicity by
Escherichia coli isolated from adults with diarrhea: suggestive evidence for an interrelationship with
serotype. Infect Immun. 1977; 17(1):105–11. PMID: 328392
46. Tobias J, von MA, Loayza FP, Aslett M, Page AJ, Sjoling A, et al. Stability of the Encoding Plasmids and
Surface Expression of CS6 Differs in Enterotoxigenic Escherichia coli (ETEC) Encoding Different Heat-
Stable (ST) Enterotoxins (STh and STp). PLoS ONE. 2016; 11(4):e0152899. https://doi.org/10.1371/
journal.pone.0152899 PMID: 27054573
47. Echeverria P, Seriwatana J, Taylor DN, Changchawalit S, Smyth CJ, Twohig J, et al. Plasmids coding
for colonization factor antigens I and II, heat-labile enterotoxin, and heat-stable enterotoxin A2 in
Escherichia coli. Infect Immun. 1986; 51(2):626–30. PMID: 3510984
48. Evans DG, Evans DJ Jr. New surface-associated heat-labile colonization factor antigen (CFA/II) pro-
duced by enterotoxigenic Escherichia coli of serogroups O6 and O8. Infect Immun. 1978; 21(2):638–
47. PMID: 80383
49. Liu J, Platts-Mills JA, Juma J, Kabir F, Nkeze J, Okoi C, et al. Use of quantitative molecular diagnostic
methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lan-
cet. 2016; 388(10051):1291–301. https://doi.org/10.1016/S0140-6736(16)31529-X PMID: 27673470
50. Levine MM, Ferreccio C, Prado V, Cayazzo M, Abrego P, Martinez J, et al. Epidemiologic studies of
Escherichia coli infections in a low socioeconomic level periurban community in Santiago, Chile. Am J
Epidemiol. 1993; 138:849–69. PMID: 8237973
51. Platts-Mills JA, Babji S, Bodhidatta L, Gratz J, Haque R, Havt A, et al. Pathogen-specific burdens of
community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). Lancet Glob
Health. 2015; (15):10-109X.
52. Satterwhite TK, Evans DG, DuPont HL, Evans DJ Jr., Role of Escherichia coli colonisation factor anti-
gen in acute diarrhoea. Lancet. 1978; 2(8082):181–4. PMID: 78384
53. Viboud GI, Jouve MJ, Binsztein N, Vergara M, Rivas M, Quiroga M, et al. Prospective cohort study of
enterotoxigenic Escherichia coli infections in Argentinean children. J Clin Microbiol. 1999; 37(9):2829–
33. PMID: 10449460
54. Lumish RM, Ryder RW, Anderson DC, Wells JG, Puhr ND. Heat-labile enterotoxigenic Escherichia coli
induced diarrhea aboard a Miami-based cruise ship. Am J Epidemiol. 1980; 111(4):432–6. PMID:
6990749
55. Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB, Young CR. Immunity to enterotoxigenic
Escherichia coli. Infect Immun. 1979; 23:729–36. PMID: 378834
56. Leach S, Lundgren A, Carlin N, Lofstrand M, Svennerholm AM. Cross-reactivity and avidity of antibody
responses induced in humans by the oral inactivated multivalent enterotoxigenic Escherichia coli
(ETEC) vaccine ETVAX. Vaccine. 2017; (17):10.
57. Barry EM, Wang J, Wu T, Davis T, Levine MM. Immunogenicity of multivalent Shigella-ETEC candidate
vaccine strains in a guinea pig model. Vaccine. 2006; 24(18):3727–34. https://doi.org/10.1016/j.
vaccine.2005.07.013 PMID: 16169130
58. Anantha RP, McVeigh AL, Lee LH, Agnew MK, Cassels FJ, Scott DA, et al. Evolutionary and functional
relationships of colonization factor antigen i and other class 5 adhesive fimbriae of enterotoxigenic
Escherichia coli. Infect Immun. 2004; 72(12):7190–201. https://doi.org/10.1128/IAI.72.12.7190-7201.
2004 PMID: 15557644
59. Gaastra W, Sommerfelt H, van DL, Kusters JG, Svennerholm AM, Grewal HM. Antigenic variation
within the subunit protein of members of the colonization factor antigen I group of fimbrial proteins in
human enterotoxigenic Escherichia coli. Int J Med Microbiol. 2002; 292(1):43–50. PMID: 12139428
60. Fleckenstein J, Sheikh A, Qadri F. Novel antigens for enterotoxigenic Escherichia coli vaccines. Expert
Rev Vaccines. 2014; 13(5):631–9. https://doi.org/10.1586/14760584.2014.905745 PMID: 24702311
61. Caron J, Scott J. A rns-like regulator gene in CFA/I that controls expression of CFA/I pilin. Infect Immun.
1990; 58:874–8. PMID: 1969396
62. Caron J, Coffield LM, Scott JR. A plasmid-encoded regulatory gene, rns, required for expression of the
CS1 and CS2 adhesins of enterotoxigenic Escherichia-coli. Proc Natl Acad Sci USA. 1989; 86:963–7.
PMID: 2563591
63. Bodero MD, Munson GP. The Virulence Regulator Rns Activates the Expression of CS14 Pili. Genes
(Basel). 2016; 7(12):genes7120120.
ETEC colonization factors from a global diarrhea study
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007037 January 4, 2019 26 / 27
64. Haines S, Gautheron S, Nasser W, Renauld-Mongenie G. Identification of Novel Components Influenc-
ing Colonization Factor Antigen I Expression in Enterotoxigenic Escherichia coli. PLoS ONE. 2015; 10
(10):e0141469. https://doi.org/10.1371/journal.pone.0141469 PMID: 26517723
65. Haines S, Arnaud-Barbe N, Poncet D, Reverchon S, Wawrzyniak J, Nasser W, et al. IscR Regulates
Synthesis of Colonization Factor Antigen I Fimbriae in Response to Iron Starvation in Enterotoxigenic
Escherichia coli. J Bacteriol. 2015; 197(18):2896–907. https://doi.org/10.1128/JB.00214-15 PMID:
26124243
66. Hodson C, Yang J, Hocking DM, Azzopardi K, Chen Q, Holien JK, et al. Control of Virulence Gene
Expression by the Master Regulator, CfaD, in the Prototypical Enterotoxigenic Escherichia coli Strain,
H10407. Front Microbiol. 2017; 8:1525. https://doi.org/10.3389/fmicb.2017.01525 eCollection;%
2017.:1525. PMID: 28848532
67. Wolf MK, Andrews GP, Tall BD, McConnell MM, Levine MM, Boedeker EC. Characterization of CS4
and CS6 antigenic components of PCF8775, a putative colonization factor complex from enterotoxi-
genic Escherichia coli E8775. Infect Immun. 1989; 57:164–73. PMID: 2491834
68. Caron J, Maneval DR, Kaper JB, Scott JR. Association of RNs Homologs with Colonization Factor Anti-
gens in Clinical Escherichia-Coli Isolates. Infect Immun. 1990; 58:3442–4. PMID: 2205583
69. Favre D, Ludi S, Stoffel M, Frey J, Horn MP, Dietrich G, et al. Expression of enterotoxigenic Escherichia
coli colonization factors in Vibrio cholerae. Vaccine. 2006; 24(20):4354–68. https://doi.org/10.1016/j.
vaccine.2006.02.052 PMID: 16581160
70. Nicklasson M, Sjoling A, von MA, Qadri F, Svennerholm AM. Expression of colonization factor CS5 of
enterotoxigenic Escherichia coli (ETEC) is enhanced in vivo and by the bile component Na glycocholate
hydrate. PLoS ONE. 2012; 7(4):e35827. https://doi.org/10.1371/journal.pone.0035827 PMID:
22563407
71. Nicklasson M, Sjoling A, Lebens M, Tobias J, Janzon A, Brive L, et al. Mutations in the periplasmic
chaperone leading to loss of surface expression of the colonization factor CS6 in enterotoxigenic
Escherichia coli (ETEC) clinical isolates. Microb Pathog. 2008; 44(3):246–54. https://doi.org/10.1016/j.
micpath.2007.06.009 PMID: 18037262
ETEC colonization factors from a global diarrhea study
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007037 January 4, 2019 27 / 27
